Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07111663 · ClinicalTrials.gov registry record
An Observational Study of Individuals With Isolated Dystonia
A clinical trial of Isolated/Primary Dystonia That Affects More Than One Region of the Body, sponsored by Vima Therapeutics.
- Recruiting
- Registry status
- 200
- Enrollment target
- 20
- Study locations
NCT07111663 is a study of Isolated/Primary Dystonia That Affects More Than One Region of the Body that is actively recruiting participants, run by Vima Therapeutics. The registered enrollment target is 200 participants. The trial reports 20 study locations across 12 states.
The verdict
NCT07111663, a study of Isolated/Primary Dystonia That Affects More Than One Region of the Body, is actively recruiting participants, sponsored by Vima Therapeutics.
- RECRUITING
- Registry status
- 200 participants
- Enrollment target
- 20
- Study locations
Study Summary
This is an observational study in individuals with isolated (or primary) dystonia that involves more than one body region. The purpose of the study is to collect detailed information to help your physician and other researchers understand how dystonia impacts your and other patients' lives and how the disease changes over time. The study may also help researchers better understand the clinical scales that are commonly used to evaluate dystonia symptoms and how they affect various areas of life such as well-being, pain, relationships and social interactions, and progress over time. Because this is an observational study, you will not receive any interventional treatment in the study.
Conditions Studied
Study Locations (20)
Florida
- Vima Site #003 - Boca Raton
- Vima Site #009 - Gainesville
- Vima Site #008 - Miami
- Vima Site #031 - Orlando
California
- Vima Site #010 - Aliso Viejo
- Vima Site #030 - Los Angeles
- Vima Site #022 - Palo Alto
New York
- Vima Site #017 - Commack
- Vima Site #018 - New York
- Vima Site #024 - New York
Arizona
- Vima Site #004 - Scottsdale
- Vima Site #028 - Sun City
Colorado
- Vima Site #019 - Englewood
Georgia
- Vima Site #005 - Atlanta
Illinois
- Vima Site #027 - Chicago
Maryland
- Vima Site #007 - Olney
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2025-06-17 |
| Est. Completion | 2026-10 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07111663
The ClinicalTrials.gov registry entry for NCT07111663 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Vima Therapeutics, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Isolated/Primary Dystonia That Affects More Than One Region of the Body appearing as the primary indexed condition, and to 0 interventions.
NCT07111663 reports 20 study locations spanning 12 distinct geographic areas - top geographies include Florida, California, New York.
Frequently Asked Questions
What is clinical trial NCT07111663 about?
NCT07111663 is a clinical study titled "An Observational Study of Individuals With Isolated Dystonia". This is an observational study in individuals with isolated (or primary) dystonia that involves more than one body region. The purpose of the study is to collect detailed information to help your physician and other researchers understand how dystonia impacts your and other patients' lives and how t...
What is the current status of trial NCT07111663?
This trial is currently recruiting. The enrollment target is 200 participants. The study started on 2025-06-17. Estimated completion is 2026-10.
What conditions does trial NCT07111663 study?
This clinical trial studies the following conditions: Isolated/Primary Dystonia That Affects More Than One Region of the Body.
Who is sponsoring clinical trial NCT07111663?
This trial is sponsored by Vima Therapeutics, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07111663 being conducted?
This trial has 20 study locations across Arizona, California, Colorado, Florida, Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.